Biotechnology company Amgen has agreed to acquire privately held biopharmaceutical company Rodeo Therapeutics. Under the deal, the company will acquire all Rodeo Therapeutics’ outstanding shares for a $55m
The post Amgen agrees to acquire biopharmaceutical company Rodeo Therapeutics appeared first on Pharmaceutical Business review.